• About
  • Advertise
  • Careers
Tuesday, May 20, 2025
  • Login
No Result
View All Result
Hindustan Surkhiyan
66 °f
Columbus
  • World
  • USA
  • New York
  • Bangladesh
  • India
  • Sports
  • Entertainment
  • Science & Tech
  • More
    • Opinion
    • Fashion
    • Business & Economy
    • Interview
    • Literature
      • poetry
    • Lifestyle
      • Biography
    • Nature
    • Travels
    • Cartoons
  • বাংলা
  • World
  • USA
  • New York
  • Bangladesh
  • India
  • Sports
  • Entertainment
  • Science & Tech
  • More
    • Opinion
    • Fashion
    • Business & Economy
    • Interview
    • Literature
      • poetry
    • Lifestyle
      • Biography
    • Nature
    • Travels
    • Cartoons
  • বাংলা
No Result
View All Result
Hindustan Surkhiyan
Home India

India tests samples of cough syrup linked to deaths of children in Gambia

October 6, 2022
in India
Reading Time: 2 mins read
A A
India tests samples of cough syrup linked to deaths of children in Gambia
7
VIEWS
Share on FacebookShare on Twitter

India is testing samples of cough syrups produced by Maiden Pharmaceuticals for exports after the World Health Organization said its products were linked to the deaths of dozens of children in Gambia, the country’s health ministry said on Thursday, reports Reuters.

The deaths of 66 children in the West African country is a blow to India’s image as a “pharmacy of the world” that supplies medicines to all continents, especially Africa.

The WHO on Wednesday said laboratory analysis of four Maiden products – Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup – had confirmed “unacceptable” amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury.

Diethylene glycol and ethylene glycol are used in antifreeze and brake fluids and other industrial applications but also as a cheaper alternative in some pharmaceutical products.

India’s health ministry said samples of the same batch manufactured by Maiden for all four drugs has been sent for testing to a federal laboratory and the results would “guide further course of action as well as bring clarity on the inputs received/to be received from WHO.”

It asked the WHO to share its report on “establishment of causal relation to death with the medical products in question.”

The WHO did not immediately respond to an emailed request for comment.

Anil Vij, the health minister of Haryana state where Maiden has its factories, warned of “strict action if anything is found wrong” after the tests.

Naresh Kumar Goyal, a Maiden director, told Reuters that it heard about the deaths only on Thursday morning and were trying to find out details.

“We are trying to find out the situation because it cropped up only today,” he said by phone. “We are trying to find out with the buyer and all that what has happened exactly. We are not selling anything in India.” He declined to speak further.

WHO Director-General Tedros Adhanom Ghebreyesus told reporters on Wednesday that the U.N. agency was investigating the deaths from acute kidney injuries with India’s drug regulator and the drug maker.

The agency informed the Drugs Controller General of India of the deaths late last month after which the regulator launched an investigation with state authorities in tandem with the WHO.

Maiden, which launched its operations in November 1990, manufactured and exported the syrup only to Gambia, the Indian health ministry said. Maiden on its website says it has two manufacturing plants, in Kundli and Panipat, both near New Delhi in Haryana, and has recently set up another one.

Maiden has an annual production capacity of 2.2 million syrup bottles, 600 million capsules, 18 million injections, 300,000 ointment tubes and 1.2 billion tablets.

Maiden on its website says it sells its products at home and exports to countries in Asia, Africa and Latin America, although Goyal said they were not currently selling in India.

The health ministry said importing countries typically test such products before allowing their use.

Previous Post

World Bank cuts India’s growth forecast to 6.5pc for 2022/23

Next Post

Sydney records wettest year since 1858

Related Posts

India deportation flight likely cost US more than $1 mn

India deportation flight likely cost US more than $1 mn

February 7, 2025
Hasina’s extradition: ‘India has not responded to Dhaka’s request’

Hasina’s extradition: ‘India has not responded to Dhaka’s request’

February 7, 2025
“Brahmin Should Handle Tribal Affairs”: Minister Sparks Row, Then Clarifies

“Brahmin Should Handle Tribal Affairs”: Minister Sparks Row, Then Clarifies

February 2, 2025
Manipur Kuki Body Leader Faces Action After Mob Tries To Stop Forces From Destroying Poppy Fields

Manipur Kuki Body Leader Faces Action After Mob Tries To Stop Forces From Destroying Poppy Fields

February 2, 2025
Next Post
Sydney records wettest year since 1858

Sydney records wettest year since 1858

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Most Recent

Hindutva: From Ideology to Governance

Hindutva: From Ideology to Governance

May 19, 2025
Graves and Glory: The Human Toll of the Indo-Pak Wars

Graves and Glory: The Human Toll of the Indo-Pak Wars

May 19, 2025
To Go to War or Not: A Reflection on India’s Current Path!

To Go to War or Not: A Reflection on India’s Current Path!

May 9, 2025
India deportation flight likely cost US more than $1 mn

India deportation flight likely cost US more than $1 mn

February 7, 2025
Hasina’s extradition: ‘India has not responded to Dhaka’s request’

Hasina’s extradition: ‘India has not responded to Dhaka’s request’

February 7, 2025

Follow Us

Shah J. Choudhury
President
Husneara Choudhury
Editor
A Unit of Shah Group
USA Office: 70-52 Broadway 1A, Jackson Heights, NY 11372. Contact:‭ +1 (718) 496-5000.
Bangladesh Office: F-29, Road-01, Sector-02, Aftabnagar, Dhaka-1212.
India Office: 352, Block A, Sector 2, Rohini, New Delhi 110085. Contact: +91 987 343 8786.
Email: hindustansurkhiyan@gmail.com, www.hindustansurkhiyan.com

A Unit of Shah Group
© Copyright 2022, All Rights Reserved by Hindustan Surkhiyan
Privacy Policy   Term & Conditions

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • World
  • USA
  • New York
  • Bangladesh
  • India
  • Sports
  • Entertainment
  • Science & Tech
  • More
    • Opinion
    • Fashion
    • Business & Economy
    • Interview
    • Literature
      • poetry
    • Lifestyle
      • Biography
    • Nature
    • Travels
    • Cartoons
  • বাংলা

© Copyright 2022, All Rights Reserved by Hindustan Surkhiyan

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.